Casio brings skin cancer detectors overseas, including to US

Japanese company aims to boost medical device revenue past $9m

20210209N Casio monitor

Casio's Dermocamera takes polarized shots of lesions to help diagnose skin cancer. (Photo courtesy of Casio)

JUNICHI OSHITA, Nikkei staff writer

TOKYO -- Japanese electronics manufacturer Casio Computer will release its skin cancer detection devices in foreign markets, anticipating demand in countries with higher rates of the condition.

Casio will market its Dermocamera and dermoscope in Australia and New Zealand by March, expanding to Taiwan and the U.S. later this year. Australia had the highest rate of melanoma in 2018, followed by New Zealand, according to data compiled by the World Cancer Research Fund.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.